<--- Back to Details
First PageDocument Content
Anticoagulants / Heparins / Direct thrombin inhibitors / Coagulation system / Rivaroxaban / Dabigatran / Apixaban / Warfarin / Venous thrombosis / Chemistry / Organic chemistry / Hematology
Date: 2014-04-28 19:30:18
Anticoagulants
Heparins
Direct thrombin inhibitors
Coagulation system
Rivaroxaban
Dabigatran
Apixaban
Warfarin
Venous thrombosis
Chemistry
Organic chemistry
Hematology

Cardiology David Brieger Jenny Curnow Anticoagulation: a GP

Add to Reading List

Source URL: www.racgp.org.au

Download Document from Source Website

File Size: 330,73 KB

Share Document on Facebook

Similar Documents

A M E R I C A N  S O C I E T Y O F

A M E R I C A N S O C I E T Y O F

DocID: 1qkK5 - View Document

Monday October 10th, 2016 Amphitheatre xxx The success story of a carbohydrate” ENS Paris 29 rue d’Ulm ITMO Molecular and structural basis of life Paris 5ème

Monday October 10th, 2016 Amphitheatre xxx The success story of a carbohydrate” ENS Paris 29 rue d’Ulm ITMO Molecular and structural basis of life Paris 5ème

DocID: 1ptev - View Document

SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv

SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv

DocID: 1p0MX - View Document

April 21st, 2015  Kits for which Material Safety Data Sheets are not required The kits listed below are not labelled as hazardous. Considering the Regulation (EC) N° and the OSHA regulations 29 CFRg

April 21st, 2015 Kits for which Material Safety Data Sheets are not required The kits listed below are not labelled as hazardous. Considering the Regulation (EC) N° and the OSHA regulations 29 CFRg

DocID: 1gtqX - View Document

Guideline on non-clinical and clinical development of similar biological medicinal products containing low molecular-weight-heparins

Guideline on non-clinical and clinical development of similar biological medicinal products containing low molecular-weight-heparins

DocID: 1cDQr - View Document